Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
Recruiting now · Not applicable
Conditions studied: Transplant;Failure,Kidney, Transplant; Failure, Liver, Adherence, Medication, Adherence, Patient, Adherence, Treatment
In brief
Can the investigators create an effective way to improve adherence to immunosuppressant medication and reduce rejection, graft loss, and death in adolescents and young adults who have undergone kidney or liver transplantation? The investigators' mobile technology intervention uses real-time electronic pillbox-assessed dose timing and text message prompts to address antirejection medication nonadherence when nonadherence is detected.
Key facts
- Study ID
- NCT05613010
- Run by
- Johns Hopkins University
- People needed
- 65
- Starts
- 2024-03-19
- Expected to finish
- 2026-11-30
- Last updated by the study team
- 2026-04-13
Who can join
Age: 13 and older, up to 25. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adolescents and young adults (13-25 years old) who underwent kidney or liver transplantation at least 6 months prior to enrollment
- Currently prescribed tacrolimus or sirolimus.
You may not qualify if…
- Currently receiving dialysis
- Hospitalized for duration of study
- Significant developmental or cognitive delay
- No access to a mobile device that supports text messaging
- Decline to use electronic pill box to monitor daily medication adherence
- Non-English speaking
- If a participant meets inclusion criteria, enrolls in the study, and experiences graft failure potentially leading to dialysis in the case of kidney transplant recipients, the participant will be given the option to continue in the study if they remain on tacrolimus or sirolimus.
Where it is running
- Johns Hopkins — Baltimore, Maryland, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.